Cargando…
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19
The ongoing COVID-19 pandemic has claimed more than 6 million lives and continues to test the world economy and healthcare systems. To combat this pandemic, the biological research community has shifted efforts to the development of medical countermeasures, including vaccines and therapeutics. Howev...
Autores principales: | Logue, James, Chakraborty, Arup R., Johnson, Robert, Goyal, Girija, Rodas, Melissa, Taylor, Louis J., Baracco, Lauren, McGrath, Marisa E., Haupt, Robert, Furlong, Brooke A., Soong, Mercy, Prabhala, Pranav, Horvath, Viktor, Carlson, Kenneth E., Weston, Stuart, Ingber, Donald E., DePamphilis, Melvin L., Frieman, Matthew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372968/ https://www.ncbi.nlm.nih.gov/pubmed/35962188 http://dx.doi.org/10.1038/s42003-022-03766-2 |
Ejemplares similares
-
PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells
por: Roy, Ajit, et al.
Publicado: (2023) -
Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors
por: Chakraborty, Arup R., et al.
Publicado: (2022) -
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients
por: Sperry, Megan M., et al.
Publicado: (2023) -
Spotlight on Geminin
por: DePamphilis, Melvin L
Publicado: (2011) -
PIKfyve regulates melanosome biogenesis
por: Liggins, Marc C., et al.
Publicado: (2018)